Showing 13,101 - 13,120 results of 113,423 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.88s Refine Results
  1. 13101
  2. 13102

    Incidence rates for selected health outcomes. by Natalie Mueller (3406370)

    Published 2024
    “…</p><p>Methods</p><p>We conducted a spatial health impact assessment (HIA) of port-sourced air pollution for Barcelona for 2017 at the neighbourhood level. …”
  3. 13103
  4. 13104
  5. 13105
  6. 13106

    Effect of asymmetric (<i>a ≠ b</i>) and symmetric (<i>a  =  b</i>) parasites’ contribution to total virulence (V). by Sandeepa M. Eswarappa (156396)

    Published 2012
    “…<p>Given a pair of values (<i>a, b</i>) the contour lines in each figure represent the total virulence on the host (<i>V = aA*+bB*</i>) for different values of <i>x</i> (parasite B competition/facilitation of parasite A) and <i>y</i> (parasite A competition/facilitation of parasite B). …”
  7. 13107
  8. 13108
  9. 13109
  10. 13110

    Image_5_Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.TIF by Xuejiao Yin (5132441)

    Published 2021
    “…</p><p>Results: The incidence of WM showed an initial rapid increase from 1980 to 1993 {annual percentage change (APC), 14.1% [95% confidence interval (CI), 10 to 18.4%]}, whereas it began to stabilize from 1993 to 2016 [APC, 0.5% (95% CI, −0.3 to 1.3%)]. The WM IBM trend followed a similar pattern, with a decrease occurring around 1994. …”
  11. 13111

    Image_5_Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study.TIF by Xuejiao Yin (5132441)

    Published 2020
    “…</p><p>Results: The incidence of WM showed an initial rapid increase from 1980 to 1993 {annual percentage change (APC), 14.1% [95% confidence interval (CI), 10 to 18.4%]}, whereas it began to stabilize from 1993 to 2016 [APC, 0.5% (95% CI, −0.3 to 1.3%)]. The WM IBM trend followed a similar pattern, with a decrease occurring around 1994. …”
  12. 13112

    Supplementary file 1_Clinical application of combined anticoagulation therapy in anti-MDA5 antibody-positive associated interstitial lung disease-a retrospective study.docx by Ting Zhang (102583)

    Published 2025
    “…</p>Methods<p>A retrospective cohort study was conducted, which included 100 patients diagnosed with anti-MDA5 antibody-positive interstitial lung disease at our hospital between January 2022 and December 2024. …”
  13. 13113
  14. 13114

    Recombinant CCR5-T4L acts as a HIV-1 co-receptor and down-regulates WT-CCR5 expression on the 3T3T4 cell surface. by Qingwen Jin (767337)

    Published 2015
    “…WT-CCR5 was used as a positive control. B) CCR5 expression on the cell surface was confirmed using FACS. …”
  15. 13115
  16. 13116
  17. 13117

    Deletion of Individual <i>sod</i> Genes Does Not Decrease Lifespan Despite Increasing Sensitivity to Oxidative Stress. by Jeremy M. Van Raamsdonk (267436)

    Published 2009
    “…<p>A–E) <i>sod-1</i>(A), <i>sod-3</i>(C), <i>sod-4</i>(D) and <i>sod-5</i>(E) mutant worms live as long as wild-type N2 worms while <i>sod-2</i> mutant worms (B) live significantly longer than wild-type worms. …”
  18. 13118
  19. 13119

    qPCR primer sequences. by Shuaini Yang (20670608)

    Published 2025
    “…Meanwhile, we also observed a significant reduction in IFN-γ secretion by CD8<sup>+</sup> T cells following <i>ccr2</i> deficiency. …”
  20. 13120

    JMJD5 forms a complex with CRY1–FBXL3 and leads to CRY1 degradation. by Anand R. Saran (6034127)

    Published 2018
    “…(H) CRY1 accumulation in response to MG132 treatment is decreased in JMJD5-null cells compared to controls, whereas ubiquitylation is unaffected (<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.2006145#pbio.2006145.s010" target="_blank">S10 Fig</a>). …”